Axogen Statistics
Total Valuation
Axogen has a market cap or net worth of $495.52 million. The enterprise value is $549.46 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, before market open.
Earnings Date | May 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Axogen has 45.54 million shares outstanding. The number of shares has increased by 3.96% in one year.
Current Share Class | 45.54M |
Shares Outstanding | 45.54M |
Shares Change (YoY) | +3.96% |
Shares Change (QoQ) | -5.95% |
Owned by Insiders (%) | 1.68% |
Owned by Institutions (%) | 86.01% |
Float | 44.78M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.52 |
Forward PS | 2.19 |
PB Ratio | 4.73 |
P/TBV Ratio | 5.03 |
P/FCF Ratio | 420.97 |
P/OCF Ratio | 138.19 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 83.77, with an EV/FCF ratio of 462.12.
EV / Earnings | n/a |
EV / Sales | 2.82 |
EV / EBITDA | 83.77 |
EV / EBIT | n/a |
EV / FCF | 462.12 |
Financial Position
The company has a current ratio of 4.28, with a Debt / Equity ratio of 0.67.
Current Ratio | 4.28 |
Quick Ratio | 2.22 |
Debt / Equity | 0.67 |
Debt / EBITDA | 6.44 |
Debt / FCF | 59.71 |
Interest Coverage | -0.05 |
Financial Efficiency
Return on equity (ROE) is -7.22% and return on invested capital (ROIC) is -0.14%.
Return on Equity (ROE) | -7.22% |
Return on Assets (ROA) | -0.13% |
Return on Invested Capital (ROIC) | -0.14% |
Return on Capital Employed (ROCE) | -0.22% |
Revenue Per Employee | $430,354 |
Profits Per Employee | -$15,847 |
Employee Count | 452 |
Asset Turnover | 1.02 |
Inventory Turnover | 1.59 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +63.86% in the last 52 weeks. The beta is 1.19, so Axogen's price volatility has been higher than the market average.
Beta (5Y) | 1.19 |
52-Week Price Change | +63.86% |
50-Day Moving Average | 15.21 |
200-Day Moving Average | 15.21 |
Relative Strength Index (RSI) | 28.38 |
Average Volume (20 Days) | 748,079 |
Short Selling Information
The latest short interest is 2.02 million, so 4.43% of the outstanding shares have been sold short.
Short Interest | 2.02M |
Short Previous Month | 1.67M |
Short % of Shares Out | 4.43% |
Short % of Float | 4.50% |
Short Ratio (days to cover) | 3.81 |
Income Statement
In the last 12 months, Axogen had revenue of $194.52 million and -$7.16 million in losses. Loss per share was -$0.16.
Revenue | 194.52M |
Gross Profit | 144.29M |
Operating Income | -388,000 |
Pretax Income | -16.54M |
Net Income | -7.16M |
EBITDA | 6.56M |
EBIT | -388,000 |
Loss Per Share | -$0.16 |
Full Income Statement Balance Sheet
The company has $22.07 million in cash and $71.00 million in debt, giving a net cash position of -$48.93 million or -$1.07 per share.
Cash & Cash Equivalents | 22.07M |
Total Debt | 71.00M |
Net Cash | -48.93M |
Net Cash Per Share | -$1.07 |
Equity (Book Value) | 105.37M |
Book Value Per Share | 2.32 |
Working Capital | 71.33M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $3.62 million and capital expenditures -$2.43 million, giving a free cash flow of $1.19 million.
Operating Cash Flow | 3.62M |
Capital Expenditures | -2.43M |
Free Cash Flow | 1.19M |
FCF Per Share | $0.03 |
Full Cash Flow Statement Margins
Gross margin is 74.18%, with operating and profit margins of -0.20% and -3.68%.
Gross Margin | 74.18% |
Operating Margin | -0.20% |
Pretax Margin | -3.68% |
Profit Margin | -3.68% |
EBITDA Margin | 3.37% |
EBIT Margin | -0.20% |
FCF Margin | 0.61% |
Dividends & Yields
Axogen does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.96% |
Shareholder Yield | -3.96% |
Earnings Yield | -1.43% |
FCF Yield | 0.24% |
Dividend Details Analyst Forecast
The average price target for Axogen is $23.83, which is 119.03% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $23.83 |
Price Target Difference | 119.03% |
Analyst Consensus | Strong Buy |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | 16.54% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Axogen has an Altman Z-Score of 2.93 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.93 |
Piotroski F-Score | 4 |